ArticleBiomaterials and biosystems2021

Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection.

Michael A Bellio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.